Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase (Q35141476)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase |
scientific article |
Statements
1 reference
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase (English)
1 reference
Robert P Giugliano
1 reference
Nihar R Desai
1 reference
Payal Kohli
1 reference
William J Rogers
1 reference
Ransi Somaratne
1 reference
Fannie Huang
1 reference
Thomas Liu
1 reference
Satishkumar Mohanavelu
1 reference
Elaine B Hoffman
1 reference
Shannon T McDonald
1 reference
Timothy E Abrahamsen
1 reference
Scott M Wasserman
1 reference
Marc S Sabatine
1 reference
LAPLACE-TIMI 57 Investigators
1 reference
6 November 2012
1 reference
Identifiers
1 reference